Grove Bank & Trust’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $207K | Sell |
465
-15
| -3% | -$6.68K | 0.03% | 244 |
|
|
2025
Q1 | $233K | Buy |
480
+7
| +1% | +$3.39K | 0.03% | 222 |
|
|
2024
Q4 | $190K | Buy |
473
+63
| +15% | +$25.4K | 0.03% | 224 |
|
|
2024
Q3 | $191K | Buy |
410
+22
| +6% | +$10.2K | 0.03% | 227 |
|
|
2024
Q2 | $182K | Sell |
388
-14
| -3% | -$6.56K | 0.03% | 229 |
|
|
2024
Q1 | $168K | Hold |
402
| – | – | 0.03% | 245 |
|
|
2023
Q4 | $164K | Sell |
402
-4
| -1% | -$1.63K | 0.03% | 236 |
|
|
2023
Q3 | $141K | Sell |
406
-132
| -25% | -$45.9K | 0.03% | 244 |
|
|
2023
Q2 | $189K | Sell |
538
-12
| -2% | -$4.22K | 0.04% | 219 |
|
|
2023
Q1 | $173K | Buy |
550
+32
| +6% | +$10.1K | 0.04% | 226 |
|
|
2022
Q4 | $150K | Buy |
+518
| New | +$150K | 0.03% | 237 |
|
|
2018
Q1 | – | Sell |
-55
| Closed | -$8K | – | 451 |
|
|
2017
Q4 | $8K | Sell |
55
-65
| -54% | -$9.46K | ﹤0.01% | 458 |
|
|
2017
Q3 | $18K | Hold |
120
| – | – | 0.01% | 410 |
|
|
2017
Q2 | $15K | Buy |
120
+65
| +118% | +$8.13K | 0.01% | 412 |
|
|
2017
Q1 | $6K | Hold |
55
| – | – | ﹤0.01% | 406 |
|
|
2016
Q4 | $4K | Buy |
+55
| New | +$4K | ﹤0.01% | 498 |
|